PMV Pharmaceuticals
PMVP
PMVP
115 hedge funds and large institutions have $470M invested in PMV Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
24% less capital invested
Capital invested by funds: $614M → $470M (-$144M)
Holders
115
Holding in Top 10
4
Calls
$1.88M
Puts
$727K
Top Buyers
| 1 | +$5.46M | |
| 2 | +$4.71M | |
| 3 | +$3.54M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.43M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.01M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$6.72M | |
| 3 | -$5.92M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$5.3M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.13M |